$PVCT News Article - Provectus Biopharmaceuticals Announces Oral Presentation of Updated Data from Combination Therapy Trial of PV-10 and Keytruda for Checkpoint-Refractory Advanced Cutaneous Melanoma at Melanoma Bridge 2020
https://marketwirenews.com/news-releases/prov...00123.html